Articles by Timothy Smith, MD, RPh
The following articles can be viewed and printed
using the Adobe Acrobat Reader. Get Acrobat
Reader to easily download and print the PDF files - it's a free program!
Migraine and Comorbidities - Presented at American Headache Society 49th Scientific Assembly June 2007; also presented at National Headache Foundation Research Summit, Feb 2008
Insurance Limitations and Costs of Triptans Negatively Influences Triptan Use Adherence and Quality of Life - Presented at American Headache Society 49th Scientific Assembly June 2007; also presented at National Headache Foundation Research Summit, Feb. 2008
Is a Triptan the First Medicine You Take for Migraine - Presented at American Headache Society 49th Scientific Assembly June 2007; also presented at National Headache Foundation Research Summit, Feb. 2008
Characteristics of Migraine Patients with Significant Right to Left Shunts as Determined by Transcranial Doppler - Presented at National Headache Foundation Research Summit, Feb. 2008
Memantine for the Prophylaxis of Migraine: A Report of Three Cases
and Discussion of Pharmacology
Cardiovascular and Safety
Concerns in Using Triptans in Migraine Patients
Comparative Study of
a Combination of Isometheptene Mucate, Dichloralphenazone With Acetaminophen
and Sumatriptan Succinate in the Treatment of Migraine
Efficacy and Tolerability
of the Marketed Doses of Rizatriptan in Children and Adolescents: A Retrospective
Review
Influence of Primary
Practice Characteristics on Migraine Diagnosis
Low-Dose Tizanidine
With Nonsteroid Anti-inflammatory Drugs for Detoxification From Analgesic Rebound
Headache
Managing Patient Expectations:
the MAZE study
Pitfalls in Migraine Diagnosis
and Management
Prevalence of Self-Reported
Comorbid Functional Disorders in Working Women with Migraine, Results of a Survey
Safety and Efficacy of
PNU-142633, a Selective 5-HT1D Agonist, in Patients With Acute Migraine
Treatment of Refractory Chronic
Headache with Zonisamide: a Case Series
Low-Dose Quetiapine Fumarate
for Prophylaxis of Refractory Migraine, A Report of Five Cases
Oral Zolmitriptan is Effective
as Early as 30 Minutes in the Treatment of Migraine Associated with Menses
Migraine Attack
Profile as a Clinical Tool: Management and Treatment Implications
Variability of Presenting
Symptoms in a Population of Patients with IHS Migraine
Focused
Migraine Interventions Improve the Coordination of Care in a Provider Group
Setting
Successful application of the HCPC guidelines for management of acute migraine
in primary care
Patients
benefit when using zolmitriptan as part of a guideline-based approach to
migraine management in
primary care
Combination of Metoclopramide and/or Caffeine Does Not Improve the Efficacy of Frovatriptan
